News and Updates

South Carolina has launched a 3,000-person clinical trial to evaluate a new COVID-19 treatment, aiming to improve patient outcomes and viral recovery.

Moderna and Merck report successful Phase 3 results for their mRNA melanoma vaccine, showing significant improvements in recurrence-free survival.

Discover how Agentic AI is revolutionizing clinical trial enrollment, reducing recruitment bottlenecks, and accelerating oncology research outcomes.

Arcato announces positive Phase 1 clinical trial results and secures new funding to accelerate the development of its biopharmaceutical pipeline.

Abcuro secures $66M to accelerate clinical trials for ulviprubart, a promising new treatment for Inclusion Body Myositis. Read the latest updates here.

Discover how Amazon Bedrock AgentCore is revolutionizing clinical trials by automating patient eligibility screening and enhancing safety monitoring.

Moderna and Merck report breakthrough success in a Phase 3 trial for their personalized mRNA melanoma vaccine. Discover how this therapy changes cancer care.

AG Mednet integrates with Microsoft Office to streamline clinical trials, improve data security, and ensure regulatory compliance for research teams.

New intraoperative technology shows promise in reducing colorectal surgery risks. Learn how this novel assessment tool improves tissue safety and outcomes.

A joint trial by Moderna and Merck shows that their mRNA cancer vaccine significantly reduces melanoma recurrence when paired with Keytruda.